🇺🇸 FDA
Patent

US 8796259

N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors

granted A61PA61P13/12A61P15/00

Quick answer

US patent 8796259 (N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P13/12, A61P15/00, A61P15/08, A61P17/06